Hexarelin results are as follows: Classed as a research peptide Hexarelin (also known as examorelin) is a potent growth hormone secretagogue (GHS). It is ghrelin mimetic and an agonist of the hormone Growth hormone secretagogues receptors (GHSR). This hexapeptide derived from GHRP-6. Hexarelin belongs to the growth hormone-releasing peptides or GHRPs family. A group of small synthetic peptides that stimulate the secretion of growth hormone by the pituitary gland, like other Ghrelin specific mimetics, act (Ghrelin) receptor – GHSR, independent of GHRHR (Growth-hormone releasing hormone receptor).
Scientific Research and Hexarelin Results
Hexarelin in research significantly and dose-dependently increased plasma levels of growth hormone (GH) in both animals and humans. Hexarelin does not affect plasma levels of glucose, luteinizing hormone (LH), follicle-stimulating hormone (FSH), or thyroid-stimulating hormone (TSH), but like GHRP-2 and GHRP-6 peptides, it gently and dose-dependently stimulates the release of the proton (ACTH) and cortisol in humans. In addition, it also has cardioprotective activity in common cardiovascular diseases such as cardiac fibrosis, ischemic heart disease, heart dysfunction, and atherosclerosis
What is Hexarelin?
Hexapeptide Hexarelin belongs to the growth hormone-releasing peptide (GHRPs) family. It is a powerful growth hormone secretagogue that is derived from GHRP-6. Hexarelin secretes more growth hormone than growth hormone-releasing hormone (GHRH), and produces synergistic effects on GH release in combination with GHRH, resulting in a huge increase in plasma GH levels even with low doses of Hexarelin. It has also been shown to reverse a diet-induced by catabolism. The stimulating effect of Hexarelin on GH secretion decreases in middle age but continues in old age. Partial and reversible tolerance of growth hormone-releasing effects of Hexarelin occurs in people with long-term use.
The History of Hexarelin
Hexarelin was developed by Mediolanum Pharmacheuti. It reached Phase II clinical trials for the treatment of growth hormone deficiency (DHD) and congestive heart failure, but did not complete development and was never marketed. The therapeutic potential of Hexarelin requires further investigation. It is classed as a research chemical and so far shows many positive results. It is not for human consumption.
It has a cardioprotective activity and helps with cardiovascular diseases such as heart fibrosis, ischemic heart disease, heart dysfunction, or atherosclerosis.
- Increased lean muscle mass, promote muscle growth, strength, and productivity
- Supports the recovery of muscle fibers and tissues, it can help heal joints
- It can help strengthen and improve the nervous system
- Anti-aging and rejuvenating effects
- Improved overall regeneration
- Helps increase bone density
- Strong anti-catabolic effect
- Fat burning properties
- Cytoprotective effects
Hexarelin Side Effects
- Skin irritation at the injection site
- Carpal tunnel syndrome
- Increased prolactin levels and gynecomastia risk (stimulates prolactin to a greater extent than other growth hormone-releasing peptides)
- Elevated cortisol levels (which may be a problem in the weeks immediately after stopping Hexarelin
- Decreased insulin sensitivity
- Water retention
Hexarelin Dosage Stimulates Muscle Growth?
In studies Hexarelin results with a daily dosage that can promote the growth of muscle mass and strength, and when combined with anabolic androgenic steroids. The interactions in this direction are synergistically improved. In research and clinical trials, the optimal dose of Hexarelin is often reported as 1 mcg per 1 kg body weight 3 times daily.